properties of otherwise short-lived molecules. Using peptide phage display we identified a series of peptides having the core sequence: DICLPRWGCLW that specifically bind serum albumin from multiple species with high affinity. These peptides bind to albumin with 1 to 1 stoichiometry at a site distinct from known small molecule binding sites.
INTRODUCTION
The effectiveness of recombinant protein pharmaceuticals depends heavily on the intrinsic pharmacokinetics of the natural protein. Because the kidney generally filters out molecules below 60 kDa, efforts to reduce clearance have focused on increasing molecular size through protein fusions, glycosylation or the addition of polyethylene glycol polymers (i.e. PEG) 1 . For example, fusions to large long-lived proteins such as albumin (1, 2) or the Fc portion of an IgG (3), the introduction of glycosylation sites (4) or conjugation with PEG (5-7) have been used. Through these methods, the in vivo exposure of protein therapeutics has been extended.
Small molecule drugs have long relied on their association with various plasma components to improve their pharmacokinetic properties in vivo; however, a drug associated with plasma protein is usually unavailable for binding to the target even though its half-life is extended. Since only the unbound fraction of the small molecule is generally functionally active, a fine balance must be maintained between the concentration of free drug required for efficacy and the frequency at which it must be administered (8) .
Albumin (molecular weight ~ 67 kDa) is the most abundant protein in plasma, present at 50 mg/ml (600 µM), and has a half-life of 19 days in humans (9, 10) . Albumin serves to maintain plasma pH, contributes to colloidal blood pressure, functions as carrier of many metabolites and fatty acids, and serves as a major drug transport protein in plasma. There are several major small molecule binding sites in albumin that have been described. Warfarin is known to bind at site I, benzodiazepines and indoles at site II and by guest on September 1, 2017 http://www.jbc.org/ Downloaded from 7/9/02 cardenolides and biliary acids at site III. In addition, there is an important metal ion binding site.
Non-covalent association with albumin has been shown to extend the half-life of short-lived proteins. A recombinant fusion of the albumin binding domain from
Streptococcal protein G to human complement receptor type 1 increased its half-life 3-fold to 5 h in rats (11) . In addition, fusion to this domain has served to enhance the immunological response directed to peptide antigens (12) . In another example, when insulin was acylated with fatty acids to promote association with albumin (13, 14) , a protracted effect was observed when injected subcutaneously in rabbits or pigs.
Together, these studies demonstrate a linkage between albumin binding and prolonged action.
In this report, peptide phage display was used to develop peptides that selectively bind albumin with high affinity. These peptides bind to albumin from multiple species at a novel site distinct from the known classical binding sites. To test whether association of a short-lived protein with albumin could improve its pharmacokinetic properties, one albumin binding peptide was added to a Fab through the use of a simple recombinant fusion that rendered it capable of binding albumin without affecting antigen binding. We demonstrate this approach as a viable route to increasing the half-life of potentially important protein pharmaceuticals. 
METHODS

Phage Libraries and Selection Conditions -Eighteen phage libraries expressing
random peptide sequences fused to the major coat protein, P8 (15) were pooled into 4 groups: Pool A contained CX 2 GPX 4 C, X 4 CX 2 GPX 4 CX 4 , and X i CX j CX k where j = 8-10;
Pool B contained X 20 and X i CX j CX k where j = 4-7; Pool C contained X 8 and X 2 CX j CX 2
where j =4-6; Pool D contained X 2 CX j CX 2 where j =7-10. X represents any of the 20 naturally occurring L-amino acids and in Pools A and B, i + j + k = 18 and | i -k | < 2.
Each library has in excess of 10 10 clones. 
Partial and Complete Randomization on Monovalent
Phage-A soft randomized library was designed using an oligonucleotide coding for clone RB, but synthesized with a 70-10-10-10 mixture of bases as described (16) . A fully randomized library was designed holding highly selected residues (underlined) constant: X 5 DXCLPXWGCLWX 4 ;
randomized positions (X) were coded by NNS. Both the soft randomized and fully randomized libraries were sorted against rat, rabbit and human serum albumin as above.
Peptide Synthesis-Peptides were synthesized by either manual or automated (Milligen 9050) Fmoc-based solid phase synthesis on a 0.25 mmol scale using a PEGpolystyrene resin as described (17 between SA peptides and albumin were obtained using a BIAcore 3000 (BIAcore Inc., Piscataway, NJ). Human, rabbit and rat albumin were captured on a CM5 chip using amine coupling at approximately 5000 resonance units (RU). SA peptides at 0, 0.625, 1.25, 2.5, 5, and 10 µM were injected at a flow rate of 20 µl/min for 30 seconds. The bound peptides were allowed to dissociate for 5 min before matrix regeneration using 10 mM glycine, pH 3. The signal from an injection passing over an uncoupled cell was subtracted from that of an immobilized cell to generate sensorgrams of the amount of peptide bound as a function of time. The running buffer, PBS containing 0.05% Tween-20, was used for all sample dilutions. BIAcore kinetic evaluation software (version 3.1) was used to determine K D from the association and dissociation rates using a one-toone binding model. Three male New Zealand White (NZW) rabbits were administered an intravenous (IV) bolus dose of 2 mg/kg of SA21 in PBS.
Pharmacokinetic Study of SA21 in Rabbits -
Eighteen blood samples were collected at serial time-points just prior to dosing and from 1 min to 21 days post-dosing. Samples were collected in tubes containing sodium citrate as an anticoagulant, then centrifuged and the plasma portion frozen at -70 o C until analysis using an ESI (electrospray), LC/MS/MS method. 
RESULTS
Identification and Maturation of Peptides that Bind to Serum Albumin -Naïve peptide
phage library pools A through D were selected against rat, rabbit and human albumin.
Each pool, with the exception of pool D when human albumin was the target, showed enrichment for each species of albumin. The sequences from the enriched pools revealed in each case that a single clone had taken over the pool. The inferred peptide sequences from these clones are shown in Table I .
Interestingly, albumin has greater than 70 percent amino acid sequence identity between these species yet unique peptide sequences originating from within a given phage library pool were identified for each species. The sequence similarity observed between clones HB and HC, RA and RD, and RB and RC, despite their origins from independent phage library pools, suggests the importance of the homologous residues in binding to the respective species of albumin. Individual phage clones were examined using a phage binding assay, a quick qualitative screen to assess species selectivity.
While phage clones generally bound only to the albumin for which they were selected, clones HB and HC, selected for binding to human albumin, also bound to rat albumin and clone RB, selected for binding to rat albumin, bound albumin from all 3 species (Table I) . None of the phage clones bound to structurally unrelated ovalbumin indicating that the interaction with albumin was specific.
Because of its broad recognition of rat, rabbit and human albumin, clone RB was chosen for sequence maturation on phage using 'soft randomization'. The potential diversity of a soft randomized library is the same as the starting naïve libraries, however, a soft randomized library maintains a bias towards a particular sequence, in this case, DNA coding for the peptide sequence from clone RB. Sequences after 4 rounds of selection against rat, rabbit or human albumin are shown in Table II along with results from the phage binding assay. All clones were specific for the albumin to which they were selected based upon their lack of binding to immobilized ovalbumin and casein; however, several clones also bound to albumin from other species including bovine, rhesus and mouse albumin (Table II) .
Since at any given position, the amino acid present in the parent sequence was Characterization of Albumin Binding Peptides -Several peptides patterned after the sequences selected for albumin binding were synthesized. Their binding to human, 7/9/02 rabbit and rat albumin was assessed by Biacore and a peptide competition assay was used to assess their affinity for rabbit and mouse albumin (Tables III and IV). The IC 50 values obtained for binding to rabbit albumin compared favorably to Kd values determined by Biacore (Table III) . In comparison to rabbit and rat albumin, the peptides bind weaker to human and tighter to mouse albumin, however, the rank affinity of a given peptide is generally maintained from species to species. Peptide SA15, representing the consensus for binding rabbit albumin (Figure 1 ), had the lowest IC 50 value in the peptide binding assay and highest affinity by surface plasmon resonance for rabbit albumin (Table III) . A linear peptide, identical to SA06, but with both Cys residues changed to Ala had an IC 50 greater than 50 µM demonstrating the importance of the disulfide. In addition, the affinity of the peptides for rabbit albumin diminished with reduction in the length of the peptides (Table IV) . A core of about 10 amino acids (SA34 and SA19, Table IV ) having an IC 50 of ca. 25 µM, could be improved 6-fold by the addition of 4 residues to its amino terminus (SA33) or 8.6-fold by the addition of 3 residues to its carboxy terminus (SA26). The addition of all 7 residues resulted in a 60-fold improvement in the IC 50 (SA22) indicating that these additions have an additive effect.
Characterization of the Albumin Binding Site-When the binding of RB-B8 or RB-H1
phage to rabbit albumin was monitored over a pH range from 2.9 to 9.0, optimum binding was observed above pH 6.0 for both clones (data not shown). Binding decreased below pH 6.0 until no binding was observed at pH 2.9. A similar pattern was observed for the binding of these clones to human and rat albumin. The similar amino concentrations up to 100 µM had no effect on SA08b peptide binding to rat or rabbit albumin in the peptide competition assay (not shown).
We were curious as to whether unrelated clones initially identified for binding to albumin (Table I ) might compete with our matured multi-species binding peptides. While RD and BA phage selectively bind only to rat and rabbit albumin, respectively, these clones were clearly blocked by the addition of SA08 (Figure 2 ). In contrast, binding of clones HA and HB to human albumin was not blocked by SAO8 and thus bind to a different site.
Pharmacokinetics of SA21 -In vivo, peptides can be rapidly metabolized or eliminated due to glomerular filtration resulting in a short half-life. We hypothesized that association with albumin would result in a peptide with improved pharmacokinetics and chose to study SA21 because it was stable in citrated rabbit serum in vitro over a 24 h period at 37 o C as monitored by LC/MS/MS. With its high affinity for rabbit albumin (Table III) and the high concentration of albumin in plasma, we calculated that SA21
should remain greater than 99.95% bound to rabbit albumin in vivo. The pharmacokinetic profile of SA21 in rabbit is shown in Figure 3 compared to an unrelated control peptide of similar size, 1a (Ac-ALCDNPRIDRWYCQFVEG-NH2) and an engineered variant which binds to albumin, 1m (an amino terminal napthalene acyl sulfonamide derivative of 1a) (22). SA21 showed reduced clearance compared to 1a
and 1m with a significantly longer half-life of 2.3 h compared to 7.6 and 30 min, respectively ( Table V) . binding to albumin is also unaffected over a broad pH range from 6 to 9. Apparently this conserved peptide binding site on albumin is unique and remains unperturbed above pH 8 where albumin is known to undergo a conformational change (9) . Whether conformational changes in the structure of albumin at low pH or side chain titration contributes to a loss of peptide binding remains to be determined.
Characterization of Albumin Binding
Most peptides are rapidly cleared in vivo as a result of metabolism and renal filtration (24). The 2.3 h half-life of SA21 in rabbit is relatively long when compared to other peptides of similar size presumably owing to its association with albumin. The half-life of the coagulation factor VIIa peptide exosite inhibitor 1a, for example, is only 7.6 min in 7/9/02 rabbits but can be prolonged 4-fold by the addition of aromatic groups to its amino terminus to induce binding to albumin (22). While both peptides were stable in citrated rabbit serum for 24 h, differences in metabolism in vivo may occur. Alternatively, differences in the affinities of SA21 and 1m for rabbit albumin may explain the superior pharmacokinetic profile observed for SA21 ( Figure 3) ; the affinity of 1m for rabbit albumin was not reported.
In another example, the in vivo response to insulin was prolonged using insulin derivatives acylated with fatty acids to enable association of the hormone with albumin (14) . Unlike these chemically modified peptides, however, the association of SA21 with albumin is achieved through an amino acid peptide sequence that can simply be added to any recombinantly expressed protein. compared to D3H44-L likely due to the absence of the nearby disulfide between the light and heavy chain of the Fab. The loss of this disulfide had no effect on the ability of D3H44-Ls to bind to TF or albumin, but is associated with a 40% increase in drug clearance relative to D3H44-L, as evidenced from the pharmacokinetic study in rabbit (Table V) (Table IV) , however, this is also likely to reduce the half-life.
Besides renal filtration, metabolism is an important parameter affecting half-life.
Although clearance is greatly reduced relative to the D3H44 Fab, both SA21 and D3H44-L are cleared faster than one might expect simply based on their calculated free Interestingly, these half-lives correlate with the reported half-life of albumin in these species of 5 to 6 days in rabbit (29) and 1 day in mouse (30). Despite potential metabolism differences and the weaker affinity for human albumin (Table 3) RD (Ο), BA ( ), HA ( ) and HB ( ) phage binding to immobilized rat, rabbit or human albumin, respectively, was inhibited by increasing concentrations of peptide SA08.
Relative phage binding was determined using the phage binding assay. 
Clones Selected for Binding to Rabbit Serum Albumin
Clones Selected for Binding to Rat Serum Albumin
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Phage Binding
Clones Selected for Binding to Human Serum Albumin RB-H1 Selected peptides were tested for binding human (HSA), rabbit (BuSA), rat (RSA) and mouse (MSA) albumin using the peptide competition assay or surface plasmon resonance as indicated and described in the methods. Ac-I C L P R W G C >250000 
